Document is current
Any future updates will be listed below
-
Authors
Kawashima, Yosuke
Harada, Toshiyuki
Fujita, Yuka
Nakagawa, Taku
Watanabe, Kana
Morikawa, Naoto
Takamura, Kei
Kanazawa, Kenya
Kuda, Tomoya
Usui, Kazuhiro
Sekine, Akimasa
Inoue, Akira
Sugawara, Shunichi https://orcid.org/0000-0002-3427-4558
- License Information
-
More Information
Article History
Received: 11 July 2020
Accepted: 29 October 2020
First Online: 13 November 2020
Compliance with ethical standards
:
: Toshiyuki Harada received Honoraria from Nippon Boehringer Ingelheim, Hisamitsu Pharmaceutical Co., Inc., and GlaxoSmithKline K.K. Yuka Fujita received personal fees from Eli Lilly. Akimasa Sekine received personal fees from Taiho Pharmaceutical and Eli Lilly. Akira Inoue received Honoraria from Eli Lilly, Chugai Pharma, Taiho Pharmaceutical, AstraZeneca, Nippon Boehringer Ingelheim, and MSD K.K. Shunichi Sugawara received personal fees from AstraZeneca, Chugai Pharma, Pfizer, Taiho Pharmaceutical, Eli Lilly, Novartis, Kyowa Hakko Kirin, Bristol-Myers Squibb, Ono Pharmaceutical, MSD K.K, and Nippon Boehringer Ingelheim. All other authors declare no conflict of interest.
